Loading...

The current price of STE is 252.12 USD — it has increased 0.13 % in the last trading day.
STERIS Plc is a provider of products and services that support patient care with an emphasis on infection prevention. Its segments include Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. Its Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. AST segment supports medical device and pharmaceutical manufacturers through a global network of contract sterilization and laboratory testing facilities, and integrated sterilization equipment and control systems. Its Life Sciences segment provides a comprehensive offering of products and services designed to support biopharmaceutical and medical device research and manufacturing facilities, in particular those focused on aseptic manufacturing. Its portfolio includes a full suite of consumable products, equipment maintenance, specialty services, and capital equipment.
Wall Street analysts forecast STE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for STE is 289.33 USD with a low forecast of 285.00 USD and a high forecast of 295.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
STERIS plc revenue for the last quarter amounts to 1.46B USD, increased 9.89 % YoY.
STERIS plc. EPS for the last quarter amounts to 1.95 USD, increased 29.14 % YoY.
STERIS plc (STE) has 17787 emplpoyees as of December 15 2025.
Today STE has the market capitalization of 24.71B USD.